Proliferation-related pathways (e.g., E2F targets, MYC targets, cell cycle) are downregulated while immune activation signatures (e.g., interferon response, p53 pathway, TNF-α/NF-κB signaling) are upregulated in Zbp1−/− tumor cells. Here, TNF is linked to neoplasm.